[jksmith]

Well the hippie lettuce situation is an interesting outlier. Just as much an exception, it's also not in the main workflow of pharma because of the heavy agri origin. But that also means big agri is also probably keeping a close eye on it along the lines of either the delivery method will remain primarily like that of tobacco, or pharma will take a huge chunk of the business selling a synthetic in pill form. Either way, if it turns into big business, I don't see a place for boutique operators. Big agri or pharma will squeeze the the small farmers out somehow. Larger pharmers with thousands of acres might do well with it. Third tier pharma will again be squeezed out unless some investment the magnitude of Berkshire takes an interest.